A Case of Drug-Induced Hepatitis due to Bortezomib in Multiple Myeloma |
Kim, Young-Woon
(Division of Hematology, Department Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea)
Kim, Ka-Young (Division of Hematology, Department Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) Lee, Su-Hyun (Division of Hematology, Department Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) Chung, Yoon-Yung (Division of Hematology, Department Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) Yahng, Seung-Ah (Division of Hematology, Department Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) Lee, Sung-Eun (Division of Hematology, Department Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) Park, Gyeong-Sin (Department of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) Min, Chang-Ki (Division of Hematology, Department Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea) |
1 | Adams, J., V. J. Palombella, E. A. Sausville, J. Johnson, A. Destree, D. D. Lazarus, J. Maas, C. S. Pien, S. Prakash, and P. J. Elliott. 1999. Proteasome inhibitors: a novel class of potent and effective antitumor agents. Cancer Res. 59: 2615-2622. |
2 | Hideshima, T., P. Richardson, D. Chauhan, V. J. Palombella, P. J. Elliott, J. Adams, and K. C. Anderson. 2001. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res. 61: 3071-3076. |
3 | Richardson, P. G., B. Barlogie, J. Berenson, S. Singhal, S. Jagannath, D. Irwin, S. V. Rajkumar, G. Srkalovic, M. Alsina, R. Alexanian, D. Siegel, R. Z. Orlowski, D. Kuter, S. A. Limentani, S. Lee, T. Hideshima, D. L. Esseltine, M. Kauffman, J. Adams, D. P. Schenkein, and K. C. Anderson. 2003. A phase 2 study of bortezomib in relapsed, refractory myeloma. N. Engl. J. Med. 348: 2609-2617. DOI ScienceOn |
4 | Karin, M. and A. Lin. 2002. NF-kappaB at the crossroads of life and death. Nat. Immunol. 3: 221-227. |
5 | Rosinol, L., S. Montoto, M. T. Cibeira, and J. Blade. 2005. Bortezomib-induced severe hepatitis in multiple myeloma: a case report. Arch. Intern. Med. 165: 464-465. DOI ScienceOn |
6 | Ghobrial, I. M. and S. V. Rajkumar. 2003. Management of thalidomide toxicity. J. Support. Oncol. 1: 194-205. |
![]() |